Hold. Eckert & Ziegler's 54/100 Growth Compounder Score reflects solid momentum, with 75% bullish analyst sentiment and 30.1% average alpha, but a 86.2× forward P/E leaves minimal room for execution missteps. Leadership alignment is adequate (73.8/100), yet the Vulnerability Index of 100 flags financial buffer as the sole cushion against cyclical headwinds in medical isotopes—a narrow moat against industry disruption.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for BE:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 68/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates BE (BE) at 68/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. Eckert & Ziegler's 54/100 Growth Compounder Score reflects solid momentum, with 75% bullish analyst sentiment and 30.1% average alpha, but a 86.2× forward P/E leaves minimal room for execution missteps. Leadership alignment is
BE's current Stocky Verdict is 68/100, placing it in the "Hold" band. This composite combines a 54/100 Compounder score, 74/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for BE yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
BE scores 74/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
BE's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to BE.
Sign up free and unlock the full analysis on BE — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for BE in the app.
